Bayesian Capital Management’s Pediatrix Medical MD Stock Holding History

Bayesian Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,300	Closed	-$263K	–	698
2025 Q2	$263K	Buy	+18,300	New	+$251K	0.04%	409
2025 Q1	–	Sell	-14,500	Closed	-$190K	–	815
2024 Q4	$190K	Buy	+14,500	New	+$200K	0.02%	573
2023 Q2	–	Sell	-20,553	Closed	-$306K	–	960
2023 Q1	$306K	Buy	+20,553	New	+$311K	0.04%	501
2022 Q1	–	Sell	-8,850	Closed	-$241K	–	860
2021 Q4	$241K	Buy	+8,850	New	+$237K	0.08%	289
2018 Q2	–	Sell	-16,491	Closed	-$917K	–	662
2018 Q1	$917K	Buy	+16,491	New	+$904K	0.23%	139

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bayesian Capital Management's MD Position: Q3 2025 in Review

Bayesian Capital Management sold out of Pediatrix Medical (MD) in Q3 2025, closing a stake of 18,300 shares — an estimated $263K sold.

Bayesian Capital Management first reported a position in MD in Q1 2018 and held it in 5 quarters. The position peaked at $917K in Q1 2018. 268 funds tracked by Wall St. Rank hold MD as of Q3 2025.

Bayesian Capital Management reported no remaining Pediatrix Medical position as of Q3 2025 after selling out during the quarter.
Bayesian Capital Management sold 18,300 Pediatrix Medical shares in Q3 2025, an estimated $263K.
Bayesian Capital Management first reported a position in Pediatrix Medical in Q1 2018 and held it in 5 quarters.
Bayesian Capital Management's Pediatrix Medical position peaked at $917K in Q1 2018.
268 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.